Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the long-term safety and effectiveness of
open-label clobazam in the treatment of drop seizures in subjects with LGS.